Guest guest Posted April 16, 2005 Report Share Posted April 16, 2005 http://implants.clic.net/tony/Corner4/068.htm FOR MORE INFORMATION Keeling (281/444-0662) keeling.m@... FDA'S NEW BREAST IMPLANT BOOKLET 2000 Houston, TX -- The FDA last week released on their website (www.fda.gov/cdrh/breastimplants ) a new consumer booklet on breast implants which includes photographs of complications for the first time. This is a victory for consumer advocates who have been working to counter the plastic surgeons only showing positive outcomes to women considering implants. One look at what one woman's breasts look like after implants were removed, should give all women second thoughts about ever choosing to get implants in the first place. For women who currently have ruptured, leaking gel-filled implants and are thinking about having them removed, it should be pointed out that with a skilled surgeon and with a mastopexy, more desirable results can be obtained. Women should be warned it often costs twice or three times as much to get implants removed, as it does to get them in the beginning. The FDA is once again allowing silicone gel-filled breast implants for augmentation purposes, in spite of the fact that no manufacturer has ever been able to prove them to be either safe or effective. The FDA's own research documents a 69% rupture rate with gel found outside the scar capsule 21% of the time. Women of child-bearing age should be aware of the following statement found in the booklet, " It is not known if a small amount of silicone may pass from the shell of an implant into breast milk. If this occurs, it is not known what effect it may have on the nursing infant. " The chemical companies and the manufacturers of implants try to mislead the public, the FDA, and the Institute of Medicine (IOM) into believing there are no current methods for detecting silicone levels in breast milk. Research published in 1998, paid for by Dow Corning, the Plastic Surgery Education Foundation, and the American Society of Plastic and Reconstructive Surgeons, attempts to manipulate science by using " silicon " (the second most abundant element on earth) as a measurement in 15 lactating breast-implanted women - to declare that breast feeding is not harmful. When in fact, research published in 1997 by Baylor College of Medicine establishes the ability of new high powered equipment (GC/AED and GC/MS) to detect silicones in the nanogram range. Additional research in 1997, found platinum (used as a catalyst in the preparation of silicone gels) was leaking from gel-filled implants and could be measured by using ICP-MS. In Western Europe, but not the United States, women with silicone breast implants are advised not to breast feed. It has been stated that one of the exits for fat-soluble chemicals in women's breast tissue is through lactation, perhaps explaining why women who have not nursed infants are at higher risk for breast cancer. But are we unloading toxic contaminants into the bodies of our babies? Chemically Associated Neurological Disorders (CANDO) has been granted a meeting with the Office of Device Evaluation at the FDA on September 11th, to present preliminary data from research done by ExperTox, Inc. Indicating the platinum released from gel-filled implants is in a highly reactive toxic form. The chemical companies and manufacturers of implants have previously misled the FDA and the IOM into believing the platinum released was harmless. Symptoms of exposure to toxic platinum can include fatigue (a non-specific condition frequently associated with impaired oxygen exchange ability), sicca symptoms (dry eyes, mouth, joint inflammation, etc.), mental confusion (neurotoxicity/CNS involvement), pulmonary symptoms (cough, shortness of breath, pleuiritic chest pain, or abnormal pulmonary function test results), hair loss, and rash. ________________________________________________________________ To receive a copy of the FDA breast implant handbook 2000, readers can call the FDA at 1-888-463-6332. When prompted, press 1, press 2, press 1, press 6, and then press 2 to leave your address and have the handbook mailed to you. Keeling, is President of Chemically Associated Neurological Disorders, a nonprofit organization dedicated to education and research on the effects of various types of implants on the human body. Keeling, President and Founding Director Chemically Associated Neurological Disorders P.O. Box 682633 Houston, Tx. 77268-2633 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.